Conditional expression of a Gi-coupled receptor in osteoblasts results in trabecular osteopenia

Endocrinology

Volumn 149, Issue 3, 2008, Pages 1329-1337

  Peng, J ^a   Bencsik, M ^a   Louie, A ^a   Lu, W ^a   Millard, S ^a,b   Nguyen, P ^a   Burghardt, A ^b   Majumdar, S ^a,b   Wronski, T J ^d   Halloran, B ^a   Conklin, B R ^c   Nissenson, Robert A ^a,e  

^a Departments of Medicine and Physiology

^b Department of Radiology ^*

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

^e SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; G PROTEIN COUPLED RECEPTOR; PROTEIN RO1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MINERALIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EMBRYO DEVELOPMENT; IN VIVO STUDY; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOPENIA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BONE AND BONES; BONE DENSITY; BONE DEVELOPMENT; BONE DISEASES, METABOLIC; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; MALE; MICE; MICE, TRANSGENIC; OSTEOBLASTS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, OPIOID, KAPPA; SIGNAL TRANSDUCTION;

EID: 40849114831     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-0235     Document Type: Article

References (31)

1. Gensure RC, Gardella TJ, Juppner H 2005 Parathyroid hormone and parathyroid hormone-related peptide, and their receptors. Biochem Biophys Res Commun 328:666-678
2. sα in osteoblasts leads to differential effects on trabecular and cortical bone. J Biol Chem 280:21369-21375
3. Morley P, Whitfield JF, Willick GE 1999 Design and applications of parathyroid hormone analogues. Curr Med Chem 6:1095-1106
4. Ljunggren O, Ljunghall S 1993 The cyclic-AMP antagonist adenosine-3′,5′-cyclic monophosphosphorothioate, RP-isomer inhibits parathyroid hormone induced bone resorption, in vitro. Biochem Biophys Res Commun 193:821-826
5. Kaji H, Sugimoto T, Fukase M, Chihara K 1993 Role of dual signal transduction systems in the stimulation of bone resorption by parathyroid hormone-related peptide. The direct involvement of cAMP-dependent protein kinase. Horm Metab Res 25:421-424
6. Lau KH, Baylink DJ 1998 Molecular mechanism of action of fluoride on bone cells. J Bone Miner Res 13:1660-1667
7. Pi M, Faber P, Ekema G, Jackson PD, Ting A, Wang N, Fontilla-Poole M, Mays RW, Brunden KR, Harrington JJ, Quarles LD 2005 Identification of a novel extracellular cation-sensing G-protein-coupled receptor. J Biol Chem 280:40201-40209
8. Xie H, Tang SY, Cui RR, Huang J, Ren XH, Yuan LQ, Lu Y, Yang M, Zhou HD, Wu XP, Luo XH, Liao EY 2006 Apelin and its receptor are expressed in human osteoblasts. Regul Pept 134:118-125
9. Ofek O, Karsak M, Leclerc N, Fogel M, Frenkel B, Wright K, Tam J, Attar-Namdar M, Kram V, Shohami E, Mechoulam R, Zimmer A, Bab I 2006 Peripheral cannabinoid receptor, CB2, regulates bone mass. Proc Natl Acad Sci USA 103:696-701
10. Marinissen MJ, Gutkind JS 2001 G-protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol Sci 22:368-376
11. Coward P, Wada HG, Falk MS, Chan SD, Meng F, Akil H, Conklin BR 1998 Controlling signaling with a specifically designed Gi-coupled receptor. Proc Natl Acad Sci USA 95:352-357
12. Redfern CH, Coward P, Degtyarev MY, Lee EK, Kwa AT, Hennighausen L, Bujard H, Fishman GI, Conklin BR 1999 Conditional expression and signaling of a specifically designed Gi-coupled receptor in transgenic mice. Nat Biotechnol 17:165-169
13. Redfern CH, Degtyarev MY, Kwa AT, Salomonis N, Cotte N, Nanevicz T, Fidelman N, Desai K, Vranizan K, Lee EK, Coward P, Shah N, Warrington JA, Fishman GI, Bernstein D, Baker AJ, Conklin BR 2000 Conditional expression of a Gi-coupled receptor causes ventricular conduction delay and a lethal cardiomyopathy. Proc Natl Acad Sci USA 97:4826-4831
14. Dacquin R, Starbuck M, Schinke T, Karsenty G 2002 Mouse α1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast. Dev Dyn 224:245-251
15. Furth PA, St Onge L, Boger H, Gruss P, Gossen M, Kistner A, Bujard H, Hennighausen L 1994 Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci USA 91:9302-9306
16. Bikle DD, Sakata T, Leary C, Elalieh H, Ginzinger D, Rosen CJ, Beamer W, Majumdar S, Halloran BP 2002 Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone. J Bone Miner Res 17:1570-1578
17. Iwaniec UT, Yuan D, Power RA, Wronski TJ 2006 Strain-dependent variations in the response of cancellous bone to ovariectomy in mice. J Bone Miner Res 21:1068-1074
18. Jiang X, Kalajzic Z, Maye P, Braut A, Bellizzi J, Mina M, Rowe DW 2005 Histological analysis of GFP expression in murine bone. J Histochem Cytochem 53:593-602
19. Huang JC, Sakata T, Pfleger LL, Bencsik M, Halloran BP, Bikle DD, Nissenson RA 2004 PTH differentially regulates expression of RANKL and OPG. J Bone Miner Res 19:235-244
20. Scearce-Levie K, Lieberman MD, Elliott HH, Conklin BR 2005 Engineered G protein coupled receptors reveal independent regulation of internalization, desensitization and acute signaling. BMC Biol 3:3
21. i-coupled receptor in transgenic model of dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 280:H1653-H1659
22. Sims NA, Sabatakos G, Chen JS, Kelz MB, Nestler EJ, Baron R 2002 Regulating ΔFosB expression in adult Tet-Off-ΔFosB transgenic mice alters bone formation and bone mass. Bone 30:32-39
23. Rossert J, Eberspaecher H, de Crombrugghe B 1995 Separate cis-acting DNA elements of the mouse pro-α1(I) collagen promoter direct expression of reporter genes to different type I collagen-producing cells in transgenic mice. J Cell Biol 129:1421-1432
24. Levitzki A, Bar-Sinai A 1991 The regulation of adenylyl cyclase by receptor-operated G proteins. Pharmacol Ther 50:271-283
25. 2. Calcif Tissue Int 65:143-147
26. Miao D, He B, Jiang Y, Kobayashi T, Soroceanu MA, Zhao J, Su H, Tong X, Amizuka N, Gupta A, Genant HK, Kronenberg HM, Goltzman D, Karaplis AC 2005 Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34. J Clin Invest 115:2402-2411
27. Calvi LM, Sims NA, Hunzelman JL, Knight MC, Giovannetti A, Saxton JM, Kronenberg HM, Baron R, Schipani E 2001 Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone. J Clin Invest 107:277-286
28. Lanske B, Amling M, Neff L, Guiducci J, Baron R, Kronenberg HM 1999 Ablation of the PTHrP gene or the PTH/PTHrP receptor gene leads to distinct abnormalities in bone development. J Clin Invest 104:399-407
29. Claeysen S, Joubert L, Sebben M, Bockaert J, Dumuis A 2003 A single mutation in the 5-HT4 receptor (5-HT4-R D100(3.32)A) generates a Gs-coupled receptor activated exclusively by synthetic ligands (RASSL). J Biol Chem 278:699-702
30. s signaling in vivo. Ann NY Acad Sci 994:225-232
31. 1 receptor F435A activated solely by synthetic ligands (RASSL). J Biol Chem 280:34741-34746